Trial Profile
Mass Drug Administration of Monthly DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2020
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Acronyms MDAM
- 05 Feb 2018 Status changed from active, no longer recruiting to completed.
- 29 Sep 2016 New trial record